LH Laboratory Corp Of America Holdings

  1. Stocks
  2. Healthcare
  3. NYSE: LH

Price (delayed)

$217.87

Market cap

$18.5B

P/E Ratio

28.59

Dividend/share

$2.88

EPS

$7.62

Enterprise value

$24.1B

Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks ...

Highlights
LH's net income has plunged by 62% YoY and by 20% from the previous quarter
Laboratory Corp Of America Holdings's EPS has shrunk by 60% YoY and by 19% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.labcorp.com
Peers: DGX NEO ENZ BRLI

Key stats

What are the main financial stats of LH
Market
Shares outstanding
84.9M
Market cap
$18.5B
Enterprise value
$24.1B
Valuations
Price to earnings (P/E)
28.59
Price to book (P/B)
2.45
Price to sales (P/S)
1.43
EV/EBIT
24.13
EV/EBITDA
13.67
EV/Sales
1.78
Earnings
Revenue
$13.54B
EBIT
$998.8M
EBITDA
$1.76B
Free cash flow
$997.4M
Per share
EPS
$7.62
Free cash flow per share
$11.26
Book value per share
$88.86
Revenue per share
$152.85
TBVPS
$82.15
Balance sheet
Total assets
$16.89B
Total liabilities
$8.99B
Debt
$6.33B
Equity
$7.87B
Working capital
$1.05B
Liquidity
Debt to equity
0.8
Current ratio
1.36
Quick ratio
0.96
Net debt/EBITDA
3.18
Margins
EBITDA margin
13%
Gross margin
26.9%
Net margin
4.9%
Operating margin
7%
Efficiency
Return on assets
3.5%
Return on equity
7.1%
Return on invested capital
8.8%
Return on capital employed
7.1%
Return on sales
7.4%
Dividend
Dividend yield
1.32%
DPS
$2.88
Payout ratio
37.8%

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
0.39%
1 week
1.77%
1 month
3.98%
1 year
-6.95%
YTD
-7.48%
QTD
8.37%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$13.54B
Gross profit
$3.64B
Operating income
$950.3M
Net income
$661.2M
Gross margin
26.9%
Net margin
4.9%
The net margin has dropped by 62% year-on-year and by 21% since the previous quarter
LH's net income has plunged by 62% YoY and by 20% from the previous quarter
The operating margin has plunged by 57% YoY and by 13% from the previous quarter
Laboratory Corp Of America Holdings's operating income has shrunk by 57% YoY and by 11% QoQ

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
LH P/E details
P/E
28.59
P/B
2.45
P/S
1.43
EV/EBIT
24.13
EV/EBITDA
13.67
EV/Sales
1.78
Laboratory Corp Of America Holdings's EPS has shrunk by 60% YoY and by 19% QoQ
The price to earnings (P/E) is 52% higher than the 5-year quarterly average of 18.8 and 28% higher than the last 4 quarters average of 22.3
The company's equity fell by 22% YoY and by 10% QoQ
The P/B is 11% higher than the 5-year quarterly average of 2.2 and 11% higher than the last 4 quarters average of 2.2
LH's price to sales (P/S) is 4.7% lower than its 5-year quarterly average of 1.5 and 4.7% lower than its last 4 quarters average of 1.5

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA has shrunk by 59% YoY and by 19% QoQ
The company's return on invested capital has shrunk by 59% YoY and by 11% QoQ
LH's ROE has shrunk by 58% YoY and by 16% QoQ
Laboratory Corp Of America Holdings's return on sales has shrunk by 56% YoY and by 14% QoQ

Dividends

What is LH's dividend history
DPS
$2.88
Dividend yield
1.32%
Payout ratio
37.8%
Recent dividends

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 88% greater than its total liabilities
The quick ratio has contracted by 47% from the previous quarter and by 29% YoY
Laboratory Corp Of America Holdings's current ratio has decreased by 42% from the previous quarter and by 21% YoY
The debt is 20% smaller than the equity
LH's debt to equity is up by 29% year-on-year and by 13% since the previous quarter
The company's equity fell by 22% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.